Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?

about

Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?

Item

http://www.wikidata.org/entity/Q41253739

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Systemic Mastocytosis with Ass ...... iseases or Prognostic Factors?

@en

type

Item

label

Systemic Mastocytosis with Ass ...... iseases or Prognostic Factors?

@en

prefLabel

Systemic Mastocytosis with Ass ...... iseases or Prognostic Factors?

@en

P1476

Systemic Mastocytosis with Ass ...... iseases or Prognostic Factors?

@en

P2093

Angela Minervini

http://www.w3.org/2001/XMLSchema#string

Annamaria Giordano

http://www.w3.org/2001/XMLSchema#string

Antonella Zagaria

http://www.w3.org/2001/XMLSchema#string

Claudia Brunetti

http://www.w3.org/2001/XMLSchema#string

Cosimo Cumbo

http://www.w3.org/2001/XMLSchema#string

Crescenzio Francesco Minervini

http://www.w3.org/2001/XMLSchema#string

Giorgina Specchia

http://www.w3.org/2001/XMLSchema#string

Giuseppina Tota

http://www.w3.org/2001/XMLSchema#string

Luciana Impera

http://www.w3.org/2001/XMLSchema#string

Luisa Anelli

http://www.w3.org/2001/XMLSchema#string

P2860

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.

Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components

An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).

Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management.

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.

Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.

P304

276-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4274/TJH.2017.0014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Albano

Nicoletta Coccaro

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28351827

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5544054

http://www.w3.org/2001/XMLSchema#string